Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators-Reference-Cited by-同舟云学术

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

Published:2012-01 Issue:1 Volume:32 Page:6-38
ISSN:0333-1024
Container-title:Cephalalgia
language:en
Short-container-title:Cephalalgia

Author:

,Tfelt-Hansen Peer¹,Pascual Julio²,Ramadan Nabih³,Dahlöf Carl⁴,D'Amico Domenico⁵,Diener Hans-Christopher⁶,Hansen Jakob Møller¹,Lanteri-Minet Michel⁷,Loder Elisabeth⁸,McCrory Douglas⁹,Plancade Sandra¹⁰,Schwedt Todd¹¹

Affiliation:

1. University of Copenhagen, Denmark

2. University Hospital ‘Central de Asturias’, Spain

3. Nebraska HHS and Beatrice State Developmental Center, USA

4. Sahlgrenska University Hospital, Sweden

5. IRCCS Foundation, Milan, Italy

6. University Duisberg-Essen, Germany

7. Pôle Neurosciences Cliniques du CHU de Nice, France

8. Brigham and Women’s Hospital, USA

9. Duke University Medical Center, USA

10. University of Tromsø, Norway

11. Washington University School of Medicine, USA

Publisher

SAGE Publications

Subject

Neurology (clinical),General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0333102411417901

Reference221 articles.

1. Guidelines for Controlled Trials of Drugs in Migraine. First Edition

2. Zolmitriptan (Zomig™, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy

3. Zolmitriptan:a new acute treatment for migraine

4. Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine

5. Rizatriptan

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study;Journal of the Neurological Sciences;2024-09

2. Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective;PharmacoEconomics;2024-05-21

3. Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial;The Journal of Headache and Pain;2024-05-21

4. The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis;Headache: The Journal of Head and Face Pain;2024-04

5. Clinically significant differences in self‐reported pain scores in children with headaches;Academic Emergency Medicine;2024-02-23